Solana (HSDT) Competitors $15.65 -0.42 (-2.61%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSDT vs. DXR, ICCM, QTI, TELA, CTSO, MDAI, SRTS, PYPD, SURG, and TMDIFShould you be buying Solana stock or one of its competitors? The main competitors of Solana include Daxor (DXR), IceCure Medical (ICCM), QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), Spectral AI (MDAI), Sensus Healthcare (SRTS), PolyPid (PYPD), SurgePays (SURG), and Titan Medical (TMDIF). These companies are all part of the "medical equipment" industry. Solana vs. Its Competitors Daxor IceCure Medical QT Imaging TELA Bio Cytosorbents Spectral AI Sensus Healthcare PolyPid SurgePays Titan Medical Daxor (NASDAQ:DXR) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Does the media prefer DXR or HSDT? In the previous week, Solana had 7 more articles in the media than Daxor. MarketBeat recorded 10 mentions for Solana and 3 mentions for Daxor. Daxor's average media sentiment score of 1.11 beat Solana's score of 0.73 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solana 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, DXR or HSDT? Daxor has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Solana has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500. Which has higher valuation & earnings, DXR or HSDT? Daxor has higher earnings, but lower revenue than Solana. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaxorN/AN/AN/AN/AN/ASolana$520K32.50-$11.74M-$1.98 thousand-0.01 Do analysts prefer DXR or HSDT? Daxor presently has a consensus price target of $25.00, indicating a potential upside of 94.10%. Given Daxor's stronger consensus rating and higher probable upside, research analysts plainly believe Daxor is more favorable than Solana.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Solana 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Is DXR or HSDT more profitable? Daxor has a net margin of 0.00% compared to Solana's net margin of -7,215.25%. Daxor's return on equity of 0.00% beat Solana's return on equity.Company Net Margins Return on Equity Return on Assets DaxorN/A N/A N/A Solana -7,215.25%-699.93%-415.24% Do institutionals and insiders have more ownership in DXR or HSDT? 1.3% of Daxor shares are owned by institutional investors. Comparatively, 18.6% of Solana shares are owned by institutional investors. 59.5% of Daxor shares are owned by insiders. Comparatively, 17.9% of Solana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryDaxor beats Solana on 8 of the 12 factors compared between the two stocks. Get Solana News Delivered to You Automatically Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSDT vs. The Competition Export to ExcelMetricSolanaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.90M$6.84B$6.02B$10.34BDividend YieldN/A1.19%5.73%4.82%P/E Ratio-0.0126.6184.7826.75Price / Sales32.5027.48598.92130.97Price / CashN/A21.8525.7730.18Price / Book0.075.1312.476.64Net Income-$11.74M$178.09M$3.32B$276.55M7 Day Performance-13.82%-2.56%-0.56%-0.93%1 Month Performance107.01%6.60%8.20%6.04%1 Year Performance-95.65%3.31%75.60%40.02% Solana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSDTSolana1.1805 of 5 stars$15.65-2.6%N/A-95.6%$16.90M$520K-0.0130Gap UpDXRDaxor3.929 of 5 stars$13.81-0.6%$25.00+81.0%+48.6%$67.23MN/A0.0037Gap DownICCMIceCure Medical3.2202 of 5 stars$1.00+3.7%$2.39+138.5%+49.6%$66.23M$3.29M-6.2560High Trading VolumeQTIQT ImagingN/A$2.33+0.1%N/A+300.7%$63.26M$4.00M0.00N/APositive NewsTELATELA Bio2.3272 of 5 stars$1.52-2.9%$4.50+197.0%-38.5%$61.80M$69.30M-1.35120News CoverageCTSOCytosorbents1.9828 of 5 stars$0.94-4.5%$5.50+485.1%-17.0%$61.76M$35.60M-5.53220Positive NewsMDAISpectral AI2.9227 of 5 stars$2.42+8.5%$3.50+44.6%+85.7%$59.61M$27.55M-3.5183Gap UpHigh Trading VolumeSRTSSensus Healthcare2.9009 of 5 stars$3.41-0.6%$8.00+134.6%-51.5%$56.39M$37.56M-56.8340PYPDPolyPid3.1087 of 5 stars$3.54+1.1%$12.40+250.3%-3.7%$55.64MN/A-0.9280SURGSurgePays3.1289 of 5 stars$2.87+5.9%$9.50+231.0%+31.7%$55.37M$60.88M-1.1540TMDIFTitan MedicalN/A$0.48-0.3%N/A+1,153.6%$54.74M$17.63M-0.3850 Related Companies and Tools Related Companies DXR Competitors ICCM Competitors QTI Competitors TELA Competitors CTSO Competitors MDAI Competitors SRTS Competitors PYPD Competitors SURG Competitors TMDIF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSDT) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solana Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Solana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.